title: CTRP3 Stimulates Proliferation and Anti-Apoptosis of Prostate Cells through PKC Signaling Pathways.
abstract: C1q/TNF-related protein-3 (CTRP3) is a novel adipokine with roles in multiple cellular processes. However, little is known about its function in prostate cells. This study investigated the effects and mechanisms of CTRP3 in prostate cells. We first generated and purified CTRP3 protein in HEK 293T cells. Proliferation of RWPE-1 prostate cells was evaluated by MTT analyses under treatment with different concentrations of CTRP3 for various exposure times. The results revealed maximum enhancement of proliferation with 10 μg/mL CTRP3 for 72 h. Cell apoptosis and cell cycle were determined by TUNEL staining and flow cytometry analysis. TUNEL assay showed decreased TUNEL-positive cells in RWPE-1 prostate cells treated with CTRP3, and flow cytometry showed significantly decreased apoptotic cells upon CTRP3 treatment (treated cells, 8.34±1.175 vs. controls, 20.163±0.35) (P < 0.01). Moreover, flow cytometry analysis also showed a significant decrease of cells in the G1 phase and an increase of cells in the S and G2 phase upon CTRP3 treatment (treated cells, 42.85±1.40 vs. control, 52.77±0.90; 28.41±0.57 vs. 23.49±1.13; 27.08±1.97 vs. 22.20±1.32, respectively) (all P < 0.05). Two-dimensional gel electrophoresis and mass spectrometry identified differentially expressed proteins, including cytokeratin-19, GLRX3 and DDAH1, which were upregulated in CTRP3 treated cells, and cytokeratin-17 and 14-3-3 sigma, which were downregulated. GLRX3, DDAH1 and 14-3-3 sigma were confirmed using western blot analysis. A PKC inhibitor, staurosporine, was used to inhibit PKC activity in CTRP3 treated RWPE-1 cells. Staurosporine completely abolished the CTRP3-induced increased phosphorylation of intracellular PKC substrates and CTRP3-stimulated effect by RWPE-1 cells. Our results provide the first evidence for a physiological role of the novel adipokine, CTRP3, in prostate cells. Our findings suggest that CTRP3 could improve proliferation and anti-apoptosis of prostate cells through protein kinase C signaling pathways.
authors.affiliation: Department of Urology, Longgang District Central Hospital, Shenzhen, China.
authors.forename: Qi
authors.initials: Q
authors.lastname: Hou
authors.affiliation: Health management center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
authors.forename: Jinyan
authors.initials: J
authors.lastname: Lin
authors.affiliation: Department of Urology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
authors.forename: Wentao
authors.initials: W
authors.lastname: Huang
authors.affiliation: Department of Urology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
authors.forename: Maoyin
authors.initials: M
authors.lastname: Li
authors.affiliation: Department of Urology, Longgang District Central Hospital, Shenzhen, China.
authors.forename: Jianhua
authors.initials: J
authors.lastname: Feng
authors.affiliation: Department of Urology, Peking University Shenzhen Hospital, Shenzhen, China.
authors.forename: Xiangming
authors.initials: X
authors.lastname: Mao
mesh_terms: D017209:Apoptosis; D015153:Blotting, Western; D002453:Cell Cycle; D049109:Cell Proliferation; D002478:Cells, Cultured; D015180:Electrophoresis, Gel, Two-Dimensional; D005434:Flow Cytometry; D006801:Humans; D008297:Male; D010766:Phosphorylation; D011467:Prostate / Q000378:metabolism* / Q000473:pathology*; D011493:Protein Kinase C / Q000378:metabolism*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D048069:Tumor Necrosis Factors / Q000378:metabolism*
chemical_list: C506069:C1QTNF3 protein, human; D048069:Tumor Necrosis Factors; D011493:Protein Kinase C